ScienceDaily: Latest Science News |
- Coffee and cigarettes may protect against liver disease
- Strobe glasses improve hockey players' performance
- Nutrition report cards receive high marks in pilot program
- Evolution on molecular level
- Pilot study finds ways to better screen, recover guns from domestic violence offenders
- New tech lets cholesterol-tracking smartphone users take lifesaving selfies
- New link found between obesity, early decline in kidney function
- New screening strategy to prevent cardiovascular complications in sports
- New presurgery treatment combination more effective for women with triple-negative breast cancer
- Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer
- New combination therapy fails to delay progression of advanced breast cancer
- Changing chemo not beneficial for metastatic breast cancer patients with elevated circulating tumor cells
| Coffee and cigarettes may protect against liver disease Posted: 14 Dec 2013 11:48 AM PST Coffee and cigarette smoking may protect against the rare liver disease Primary Sclerosing Cholangitis (PSC), study shows. |
| Strobe glasses improve hockey players' performance Posted: 13 Dec 2013 05:11 PM PST Professional hockey players who trained with special eyewear that only allowed them to see action intermittently showed significant improvement in practice drills, according to a study with the NHL's Carolina Hurricanes. The eyewear features lenses that switch between transparent and opaque, producing stroboscopic visual conditions, much like a strobe light in your favorite dance club. |
| Nutrition report cards receive high marks in pilot program Posted: 13 Dec 2013 05:10 PM PST Parents receiving academic report cards throughout the school year is commonplace, but a new study shows that for healthier nutrition, parents should opt to receive a nutrition report card, too. |
| Posted: 13 Dec 2013 05:10 PM PST Researchers describe the evolution of various forms of the enzyme "dihydrofolate reductase" as it occurred from bacteria to humans. Their paper may prove useful to scientists in the design of future drugs and catalysts. |
| Pilot study finds ways to better screen, recover guns from domestic violence offenders Posted: 13 Dec 2013 01:11 PM PST More intensive screening to identify firearm owners among individuals who are subject to domestic violence restraining orders, and streamlining processes to recover guns at the time those restraining orders are served could help enforce existing laws that prohibit these offenders from having firearms, a pilot study conducted by violence prevention experts has found. |
| New tech lets cholesterol-tracking smartphone users take lifesaving selfies Posted: 13 Dec 2013 01:11 PM PST With a new smartphone device, you can now take an accurate iPhone camera selfie that could save your life -- it reads your cholesterol level in about a minute. |
| New link found between obesity, early decline in kidney function Posted: 13 Dec 2013 01:11 PM PST A new study of nearly 3,000 individuals links obesity to the development of kidney disease. |
| New screening strategy to prevent cardiovascular complications in sports Posted: 13 Dec 2013 06:48 AM PST Echocardiography with conventional M-mode and 2D modalities is a simple and cost effective way to increase the accuracy of pre-participation sports screening, according to research. |
| New presurgery treatment combination more effective for women with triple-negative breast cancer Posted: 13 Dec 2013 06:48 AM PST Adding the chemotherapy drug carboplatin and/or the antibody therapy bevacizumab to standard presurgery chemotherapy increased the number of women with triple-negative breast cancer who had no residual cancer detected at surgery, according to results of a randomized, phase II clinical trial. |
| Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer Posted: 13 Dec 2013 06:47 AM PST Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial. |
| New combination therapy fails to delay progression of advanced breast cancer Posted: 13 Dec 2013 06:47 AM PST Adding the antibody therapy ramucirumab to the chemotherapy drug docetaxel did not delay disease progression for patients with HER2-negative, advanced breast cancer, according to results of a placebo-controlled, randomized, phase III clinical trial. |
| Posted: 13 Dec 2013 06:47 AM PST For women with metastatic breast cancer who had elevated amounts of circulating tumor cells in their blood after a first line of chemotherapy, switching immediately to a different chemotherapy did not improve overall survival or time to progression, according to the results of a phase III clinical trial. |
| You are subscribed to email updates from ScienceDaily: Latest Science News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments :
Post a Comment